0001428500-13-000002.txt : 20130617 0001428500-13-000002.hdr.sgml : 20130617 20130617162701 ACCESSION NUMBER: 0001428500-13-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20130617 DATE AS OF CHANGE: 20130617 EFFECTIVENESS DATE: 20130617 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCA biopharma, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-198133 FILM NUMBER: 13917079 BUSINESS ADDRESS: STREET 1: 8001 ARISTA PLACE STREET 2: SUITE 430 CITY: BROOMFIELD STATE: CO ZIP: 80021 BUSINESS PHONE: 720-940-2200 MAIL ADDRESS: STREET 1: 8001 ARISTA PLACE STREET 2: SUITE 430 CITY: BROOMFIELD STATE: CO ZIP: 80021 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 D 1 primary_doc.xml X0706 D LIVE 0000907654 ARCA biopharma, Inc. 8001 ARISTA PLACE SUITE 430 BROOMFIELD CO COLORADO 80021 720-940-2200 DELAWARE NUVELO INC HYSEQ INC Corporation true Michael R. Bristow 8001 Arista Place, Suite 430 Broomfield CO COLORADO 80021 Executive Officer Director Patrick M. Wheeler 8001 Arista Place, Suite 430 Broomfield CO COLORADO 80021 Executive Officer Christopher D. Ozeroff 8001 Arista Place, Suite 430 Broomfield CO COLORADO 80021 Executive Officer Jean-Francois Formela 8001 Arista Place, Suite 430 Broomfield CO COLORADO 80021 Director Linda Grais 8001 Arista Place, Suite 430 Broomfield CO COLORADO 80021 Director John L. Zabriskie 8001 Arista Place, Suite 430 Broomfield CO COLORADO 80021 Director Pharmaceuticals Decline to Disclose 06 false 2013-06-04 false true true false 0 1250000 1250000 0 Assumes the exercise of warrants to purchase 625,000 shares of the Issuer's common stock at an exercise price of $2.00 per share. false 2 0 0 0 true false ARCA biopharma, Inc. /s/ Michael R. Bristow Michael R. Bristow President & CEO 2013-06-17